{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:23:31Z","timestamp":1789392211129,"version":"build-2803163510"},"reference-count":39,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Although obesity can predispose to the metabolic syndrome (MS), diabetes, and cardiovascular disease, not all obese subjects develop MS, hence the need for new indicators of risk for this syndrome. Advanced glycation end products (AGEs) correlate with factors involved in the MS, including inflammation and insulin resistance (IR). Because AGEs can be derived from food and are modifiable, it is important to determine whether they are a risk factor for MS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>The objective of this study was to assess the association of endogenous and exogenous AGEs with MS criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design:<\/jats:title>\n                  <jats:p>The following data were collected in a cross-sectional study of subjects with and without the MS: serum AGEs (sAGEs) and mononuclear cell AGEs, metabolites, pro- and antiinflammatory markers, body fat mass measures, including abdominal magnetic resonance imaging, and caloric and dietary AGE (dAGE) consumption.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting:<\/jats:title>\n                  <jats:p>The study was conducted in the general community.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants:<\/jats:title>\n                  <jats:p>Participants included 130 MS and 139 non-MS subjects of both sexes, older than 50 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>sAGEs (\u03f5N-carboxymethyllysine, methylglyoxal) were markedly elevated in obese persons with more than one other MS criteria but not in obese without MS criteria. sAGEs directly correlated with markers of IR (HOMA) and inflammation (leptin, TNF\u03b1, RAGE) and inversely with innate defenses (SIRT1, AGE receptor 1 [AGER1], glyoxalase-I, adiponectin). sAGEs correlated with dAGEs but not with calories, nutrient consumption, or fat mass measures. Consumption of dAGE, but not of calories, was markedly higher in MS than in non-MS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>High sAGEs, a modifiable risk factor for IR, may indicate risk for the MS, type 2 diabetes, and cardiovascular disease. High dietary AGE consumption and serum AGE levels may link healthy obesity to at-risk obesity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-3925","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T16:55:54Z","timestamp":1424364954000},"page":"1957-1966","source":"Crossref","is-referenced-by-count":133,"title":["Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity?"],"prefix":"10.1210","volume":"100","author":[{"given":"Jaime","family":"Uribarri","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Nephrology (J.U., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"George Institute for Global Health (M.W.), University of Oxford, Oxford OX1 3QX, United Kingdom, and University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tripp","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Pyzik","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Yee","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Tansman","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Mani","sequence":"additional","affiliation":[{"name":"Translational and Molecular Imaging Institute (V.M., Z.A.F.), The Icahn School of Medicine at Mt Sinai, New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[{"name":"Translational and Molecular Imaging Institute (V.M., Z.A.F.), The Icahn School of Medicine at Mt Sinai, New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Vlassara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology (J.U., H.V.), New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"10","key":"2020071615134922800_B1","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among U.S","volume":"27","author":"Ford","year":"2004","journal-title":"Adults. Diabetes Care"},{"issue":"6","key":"2020071615134922800_B2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.107.716159","article-title":"Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study","volume":"117","author":"Lutsey","year":"2008","journal-title":"Circulation"},{"issue":"7121","key":"2020071615134922800_B3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2020071615134922800_B4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2458-14-14","article-title":"Beyond BMI: The \u201cmetabolically healthy obese\u201d phenotype, its association with clinical\/subclinical cardiovascular disease and all-cause mortality\u2014a systematic review","volume":"14","author":"Roberson","year":"2014","journal-title":"BMC Public Health"},{"issue":"2","key":"2020071615134922800_B5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2020071615134922800_B6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrendo.2011.74","article-title":"AGE restriction in diabetes mellitus: a paradigm shift","volume":"7","author":"Vlassara","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2020071615134922800_B7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-007-0687-z","article-title":"Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study","volume":"50","author":"Kilhovd","year":"2007","journal-title":"Diabetologia"},{"issue":"6","key":"2020071615134922800_B8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/diacare.25.6.1055","article-title":"Advanced glycation end products and endothelial dysfunction in type 2 diabetes","volume":"25","author":"Tan","year":"2002","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071615134922800_B9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J Am Diet Assoc"},{"issue":"5","key":"2020071615134922800_B10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/ajcn.2009.28737","article-title":"A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases","volume":"91","author":"Birlouez-Aragon","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"2020071615134922800_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1333.001","article-title":"Historical perspective of the Maillard reaction in food science","volume":"1043","author":"Finot","year":"2005","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"2020071615134922800_B12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/87559129.2013.853774","article-title":"N-epsilon-(carboxymethyl)lysine: a review on analytical methods, formation, and occurrence in processed food, and health impact","volume":"30","author":"Nguyen","year":"2014","journal-title":"Food Rev Int"},{"issue":"11","key":"2020071615134922800_B13","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2009-0089","article-title":"Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1","volume":"94","author":"Vlassara","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071615134922800_B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00726-013-1502-4","article-title":"Suppression of native defense mechanisms, SIRT1 and PPAR\u03b3, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases","volume":"46","author":"Uribarri","year":"2014","journal-title":"Amino Acids"},{"issue":"7","key":"2020071615134922800_B15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrendo.2009.101","article-title":"SIRT1 and insulin resistance","volume":"5","author":"Liang","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"32","key":"2020071615134922800_B16","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1073\/pnas.0401588101","article-title":"Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020071615134922800_B17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/dc13-0842","article-title":"Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women","volume":"37","author":"Mark","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"2020071615134922800_B18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2337\/db11-1116","article-title":"Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2","volume":"62","author":"Monden","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"2020071615134922800_B19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-5922.2010.00177.x","article-title":"Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects","volume":"30","author":"Tahara","year":"2012","journal-title":"Cardiovasc Ther"},{"issue":"6","key":"2020071615134922800_B20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","article-title":"N\u03f5-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance","volume":"34","author":"Gaens","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2020071615134922800_B21","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc11-0091","article-title":"Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1","volume":"34","author":"Uribarri","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071615134922800_B22","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/db13-1636","article-title":"RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice","volume":"63","author":"Song","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"2020071615134922800_B23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/cclm-2012-0879","article-title":"Total plasma N\u03f5-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects","volume":"52","author":"Sebekova","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2020071615134922800_B24","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3945\/jn.111.143172","article-title":"Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults","volume":"141","author":"Semba","year":"2011","journal-title":"J Nutr"},{"issue":"25","key":"2020071615134922800_B25","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"2020071615134922800_B26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.ijo.0803696","article-title":"Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging","volume":"32","author":"Bonekamp","year":"2008","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"2020071615134922800_B27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03402014","article-title":"Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction","volume":"8","author":"Cai","year":"2002","journal-title":"Mol Med"},{"issue":"39","key":"2020071615134922800_B28","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1073\/pnas.1205847109","article-title":"Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1","volume":"109","author":"Cai","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2020071615134922800_B29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/db09-1187","article-title":"Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms","volume":"59","author":"de Kreutzenberg","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"2020071615134922800_B30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00394-013-0574-y","article-title":"Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals","volume":"53","author":"Poulsen","year":"2014","journal-title":"Eur J Nutr"},{"issue":"6","key":"2020071615134922800_B31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2215\/CJN.12891211","article-title":"Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease","volume":"7","author":"Vlassara","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2020071615134922800_B32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2004.03.004","article-title":"Prevalence of the metabolic syndrome in US populations","volume":"33","author":"Ford","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2020071615134922800_B33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/MCB.00705-08","article-title":"SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes","volume":"29","author":"Yoshizaki","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2020071615134922800_B34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI29709","article-title":"Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies","volume":"117","author":"Takemura","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"2020071615134922800_B35","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2353\/ajpath.2009.090138","article-title":"Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia","volume":"175","author":"Torreggiani","year":"2009","journal-title":"Am J Pathol"},{"issue":"2","key":"2020071615134922800_B36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1074\/jbc.M110.144097","article-title":"Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats","volume":"286","author":"Brouwers","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"2020071615134922800_B37","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1152\/ajpendo.00417.2009","article-title":"SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity","volume":"298","author":"Yoshizaki","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2020071615134922800_B38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/oby.20265","article-title":"Dietary patterns, abdominal visceral adipose tissue, and cardiometabolic risk factors in African Americans: the Jackson heart study","volume":"21","author":"Liu","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"2020071615134922800_B39","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.2337\/db14-0319","article-title":"Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity","volume":"63","author":"Scott","year":"2014","journal-title":"Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/5\/1957\/10855103\/jcem1957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/5\/1957\/10855103\/jcem1957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:33:35Z","timestamp":1594953215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/100\/5\/1957\/2829702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-3925","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}